We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.5%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
223
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.96% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
MetLife
MET
$62B
| $33.6M | 0.08% |
713,416
+183,375
| +35% | +$8.74M |
|
252
New Fortress Energy
NFE
$3.68B
| $33.5M | 0.08% |
37,215
+12,535
| +51% | +$8.98M |
|
|
GWPH
253
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $33M | 0.08% |
286,790
-18,410
| -6% | -$2.79M |
|
254
Editas Medicine
EDIT
$402M
| $32.7M | 0.08% |
1,436,800
+679,600
| +90% | +$16.8M |
|
|
GWR
255
DELISTED
Genesee & Wyoming Inc.
GWR
| $32.4M | 0.08% |
292,753
-2,996
| -1% | -$330K |
|
|
AYX
256
DELISTED
Alteryx Inc
AYX
| $32.2M | 0.08% |
300,000
-53,821
| -15% | -$6.68M |
|
257
Penumbra
PEN
$12.6B
| $32.2M | 0.08% |
239,617
+9,517
| +4% | +$1.47M |
|
258
CACI
CACI
$14B
| $32.2M | 0.08% |
139,168
-40,712
| -23% | -$8.78M |
|
259
A.O. Smith
AOS
$7.78B
| $31.9M | 0.08% |
668,054
+109,032
| +20% | +$5.04M |
|
|
AUY
260
DELISTED
Yamana Gold, Inc.
AUY
| $31.8M | 0.08% |
9,988,900
+4,343,100
| +77% | +$13.9M |
|
|
STL
261
DELISTED
Sterling Bancorp
STL
| $31.7M | 0.08% |
1,580,009
+29,901
| +2% | +$606K |
|
262
Rhythm Pharmaceuticals
RYTM
$6.73B
| $31.6M | 0.08% |
1,465,400
+573,200
| +64% | +$12.3M |
|
263
Atara Biotherapeutics
ATRA
$92.7M
| $31.4M | 0.08% |
89,027
+47,887
| +116% | +$17.9M |
|
|
DVAX
264
DELISTED
Dynavax Technologies
DVAX
| $31.3M | 0.08% |
8,751,450
+3,910,750
| +81% | +$15.2M |
|
|
QTS
265
DELISTED
QTS REALTY TRUST, INC.
QTS
| $31.2M | 0.08% |
607,547
+241,647
| +66% | +$11.5M |
|
266
Kinross Gold
KGC
$33.2B
| $31.2M | 0.08% |
6,780,000
+3,235,300
| +91% | +$15M |
|
267
Ares Management
ARES
$29.5B
| $31.1M | 0.08% |
1,160,000
| – | – |
|
268
Nike
NKE
$53.8B
| $31M | 0.08% |
330,053
+313,551
| +1,900% | +$26.9M |
|
269
SEI Investments
SEIC
$12.6B
| $30.9M | 0.08% |
520,643
+3,528
| +0.7% | +$204K |
|
270
Everest Group
EG
$14.5B
| $30.7M | 0.08% |
115,519
-137,239
| -54% | -$34.7M |
|
|
WRI
271
DELISTED
Weingarten Realty Investors
WRI
| $30.7M | 0.08% |
1,053,516
-79,297
| -7% | -$2.19M |
|
|
KL
272
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $30.6M | 0.08% |
683,200
+327,900
| +92% | +$15M |
|
273
Booz Allen Hamilton
BAH
$9.66B
| $30.2M | 0.07% |
425,113
-25,934
| -6% | -$1.84M |
|
274
Exelon
EXC
$43.5B
| $29.9M | 0.07% |
867,940
-265,615
| -23% | -$8.92M |
|
275
McKesson
MCK
$105B
| $29.8M | 0.07% |
218,336
+84,344
| +63% | +$12M |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 223 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 223 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.